Overall Technical outlook

Price Summary

On 2025-07-16, Suven Pharmaceuticals Limited's stock began at 1059.0, peaked at 1071.95, declined to 1054.4, and ended the day 0.45% higher at 1063.8, with 191992 shares traded.
The stock reached its highest price of 1334.2 and lowest price of 944.1 over the last 52 weeks.
As per recommendations from 6 analysts, SUVENPHAR's future price is expected to span between 1290.0 and 1500.0, with a mean price around 1396.6666.

Technicals

Support and Resistance: The current price is 1063.8, with support at 1048.2 and resistance at 1113.1. This range suggests that the price might move between these levels, with 1048.2 offering support and 1113.1 capping further gains for Suven Pharmaceuticals Limited.
SUVENPHAR supportResistance 6afaa8
Support/Resistance for SUVENPHAR


Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for SUVENPHAR, with no strong trend emerging.
SUVENPHAR aroon 6afaa8
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: In the latest move, the current price has surpassed the upper Bollinger Band, marking a bullish signal for SUVENPHAR. This breakout indicates that buying pressure is strong, pushing prices beyond their typical range. Such a move could suggest that the market is gaining momentum, with the potential for further upward movement.
SUVENPHAR bbands 6afaa8
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, establishing a key support level that could help uphold the market's upward trajectory. This persistent bullish outlook suggests that the market may continue to rise, with the support providing a foundation for further gains.
SUVENPHAR psar 6afaa8
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: With the K-line above both the D-line and the 80 mark, the stochastic indicator signals a bullish trend. This configuration suggests that the market is experiencing strong upward momentum, likely leading to further gains. Investors may see this as a favorable condition for potential growth.
SUVENPHAR stoch 6afaa8
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
SUVENPHAR trippleSMA 6afaa8
Tripple SMA chart for Suven Pharmaceuticals Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.